Cryoport, Inc. (CYRX): Net Income
$78.30M
Year ended 2025-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $78.30M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | -$114.76M | n/m | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | -$99.59M | n/m | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | -$37.33M | n/m | 2025-03-07, From 2022-01-01 |
| 2021-12-31 | -$275.53M | n/m | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | -$32.69M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$18.33M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$9.56M | n/m | 2020-03-10, From 2018-01-01 |
| 2017-12-31 | -$7.90M | n/m | 2019-03-13, From 2017-01-01 |
| 2016-12-31 | -$13.11M | n/a | 2018-03-08, From 2016-01-01 |
| No annual figure between 2015-03-31 and 2016-12-31. | |||
| 2015-03-31 | -$7.03M | n/m | 2016-06-28, From 2014-04-01 |
| 2014-03-31 | -$19.57M | n/m | 2015-05-19, From 2013-04-01 |
| 2013-03-31 | -$6.38M | n/m | 2014-06-25, From 2012-04-01 |
| 2012-03-31 | -$7.83M | n/m | 2013-06-25, From 2011-04-01 |
| 2011-03-31 | -$6.15M | n/a | 2012-06-27, From 2010-04-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | 2025-12-31 | $78.30M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$221.25M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$285.42M | n/m |
| Lifevantage Corp (LFVN) | 2026-06-30 | $5.07M | -48.3% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | -$6.88M | n/m |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | -$130.77M | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$196.54M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$68.92M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$20.20M | n/m |
Compare CYRX, PHAT, SNDX, LFVN side by side · Screen every company in Pharmaceutical Preparations ↗